Magneto-electric nano-particles generate local electric fields via external magnetic fields to penetrate and disrupt targeted cancer cells.
Flexible hydrogel filaments deliver durable occlusion through microcatheters without metallic support structures.
A bortezomib-tannic acid nanoparticle formulation encapsulates the drug in a non-water-soluble polymer matrix to achieve controlled release profiles.
Encapsulating core particles in a cross-linked silicone matrix prevents skin penetration and agglomeration.
A nicotine pouch filler formulation uses a specific water and ethanol solvent ratio to enhance nicotine elution.
A colon cleansing solution combines ascorbate anion with polyethylene glycol to retain water in the bowel for effective waste removal.
Segmenting the chelant from the isotope prevents radiolytic degradation while maintaining shelf life.
Segmented chambers prevent particle aggregation during conveyance, maintaining biological activity while increasing yield.
Circular RNA structures extend protein half-life and reduce immune responses by avoiding host genome integration.
Lyophilizing biopolymers at controlled temperatures achieves defined average molecular weight without extensive purification steps.
Synthetic LDL nanoparticles use chimeric peptides to target glioblastoma cells, overcoming non-specific delivery and complex transport barriers.
Varying marker weights and diameters enables distinct X-ray identification, resolving quantity measurement inaccuracies when capsules pile up.
Rapid evaporation via high-velocity gas flow prevents phase separation, yielding dense homogeneous dispersions with low residual solvent.
Hot-melt extrusion creates an amorphous decoquinate solid dispersion that overcomes low water solubility and improves intestinal absorption.
Incorporating endogenous cannabinoic acids prevents oxidation of active cannabinoids, eliminating health risks from exogenous antioxidants.
PLGA microparticles deliver ivacaftor via subcutaneous injection to maintain steady plasma levels and reduce dosing frequency.
Crosslinked electrospun hydrogel fibers maintain microbial viability and structural integrity in aqueous environments despite prior material solubility issues.
A solvent pretreatment softens a polymeric medical device region to embed therapeutic particles via impact.
AuNP-ULIM conjugates resolve the negative charge translocation bottleneck to inhibit poly-Ubl chains and sensitize cancer cells to radiation.
Continuous flow reactor mixes gelatin and solvent to produce nanoparticles with controlled size, resolving batch process inconsistencies.
Carbohydrate milling media eliminate salt removal steps and rust risks while achieving stable nanoparticle sizes below 500 nm.
An aptamer-conjugated gold nanoparticle system delivers antibodies to intracellular targets without cytotoxicity.
Lactobacillus crispatus CCFM1118 lowers colonization density without triggering antibiotic resistance.
Covalent carbohydrate moieties on PLGA carriers actively modulate immune responses, resolving passive delivery limitations in autoimmune treatment.
A breath-powered dry powder inhaler uses airflow to deaggregate medication for deep lung delivery.
Biodegradable microspheres sustain sonic hedgehog release to resolve rapid clearance issues, promoting neural regeneration.
Linking immune-stimulating compounds to glycogen nanoparticles overcomes chemoresistance by lowering drug EC50.
Polyethylene glycol coatings reduce nanoparticle adhesion to brain extracellular matrix barriers.
Segmented cryoprotectant loading combined with bulk droplet vitrification overcomes toxicity and scalability limits in hepatocyte preservation.
Nebulized ethanol and theobromine mixture reduces viral load by damaging spike proteins while balancing inhalation toxicity risks.
Cariprazine solid dispersions with low water activity excipients prevent hydrolytic degradation while preserving rapid drug release and manufacturing ease.
Freeze-drying lipid-silk mixtures preserves protein activity during microsphere formation, avoiding thermal degradation.
Michael-type addition creates permanent occlusion, preventing degradation risks associated with temporary embolization materials.
Polyamine-supported biological sorbents resist protease degradation and acidic conditions throughout the digestive system.
Metal-chelated phospholipid complexes self-assemble into nanoparticles to deliver nucleic acids, eliminating cytotoxicity from cationic lipid components.
A teverelix-TFA dosage regime uses simultaneous loading injections to achieve castration levels.
Atomized medications combined with hydrogen gas neutralize harmful radicals to reduce gastrointestinal side effects while improving absorption.
Ag-GQDs nanocomposites decorate silver nanoparticles with graphene quantum dots to enhance antibacterial activity while minimizing mammalian cell toxicity.
Fine particle lactose and coarse particle sorbitol balance filling efficiency with dosage accuracy to prevent agglomeration in pulmonary delivery systems.
Reconstituting a lyophilized bispecific antibody with an aromatic alcohol diluent accelerates high molecular weight species dissociation within twelve hours.
Monodisperse protocells use segmented silica and lipid structures to achieve targeted binding while minimizing non-specific interactions.
Extruding N-acylchitosan mixtures into acylation baths creates hydrogels that eliminate toxic solvent use while maintaining mechanical strength.
Polysaccharide excipients combined with ceramic granules create a moldable bone void filler that resists rapid absorption.
Synthetic polymeric nanoparticles act as artificial antigen-presenting cells to expand regulatory T and NK cell populations in vivo.
A PEG/PPG block copolymer matrix enables oral administration of lipophilic HCV prodrugs by preventing gel formation and maintaining high drug concentrations.
Dual sugar compositions stabilize desiccated biologics by maintaining cellular integrity during vacuum drying, preventing ice crystal damage.